Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Tressler

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Ocular Surface|July 28, 2011
Preservative use in topical glaucoma medicationsCharles S Tressler, Richard Beatty, Michael A Lemp
European Journal of Ophthalmology|January 26, 2010
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapyPaul Palmberg, Elizabeth E Kim, Kenneth K Kwok, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 23, 2016
Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal surveyKui Huang, Marla B Sultan, Duo Zhou, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 10, 2010
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked studyEve J Higginbotham, Kenneth W Olander, Elizabeth E Kim, et al.
The British Journal of Ophthalmology|April 26, 2011
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literatureCharles S Tressler, Robert L Wiseman, Theresa M Dombi, et al.
American Journal of Ophthalmology|September 9, 2018
A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort StudyMuhammad Younus, Ronald A Schachar, Min Zhang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Ocular Surface|July 28, 2011
Preservative use in topical glaucoma medicationsCharles S Tressler, Richard Beatty, Michael A Lemp
European Journal of Ophthalmology|January 26, 2010
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapyPaul Palmberg, Elizabeth E Kim, Kenneth K Kwok, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 23, 2016
Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal surveyKui Huang, Marla B Sultan, Duo Zhou, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 10, 2010
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked studyEve J Higginbotham, Kenneth W Olander, Elizabeth E Kim, et al.
The British Journal of Ophthalmology|April 26, 2011
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literatureCharles S Tressler, Robert L Wiseman, Theresa M Dombi, et al.
American Journal of Ophthalmology|September 9, 2018
A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort StudyMuhammad Younus, Ronald A Schachar, Min Zhang, et al.
Pageof 1